Skip to main content

Table 4 Systematic review of long-term survival outcomes

From: Systematic review and meta-analysis of laparoscopic and open gastrectomy for advanced gastric cancer

Author

Group

Follow-up (months)

Recurrence

DFS rate

OS rate

Huscher

LG

60 (2–88)

11

5-y: 57.3

5-y: 58.9

OG

55 (7–90)

10

5-y: 54.8

5-y: 55.7

Hur

LG

29 (6–47)

8

3-y: 71.4

3-y: 88.2

OG

6

3-y: 53.4

3-y: 77.2

Du XH

LG

25.2 (4–58)

22

NR

3-y: 81.2

OG

31

NR

3-y: 74.7

Hwang

LG

23 (9–40)

6

NR

NR

OG

23.5 (8–41)

17

NR

NR

Du J

LAG

25 (2–44)

19

NR

NR

OG

23

NR

NR

Cai

LG

22.1 (4–36)

NR

NR

3-y: 67.1

OG

NR

NR

3-y: 53.8

Scatizzi

LG

18 (2–37)

NR

NR

3-y: 70.9

OG

18 (7–42)

NR

NR

3-y: 56.8

Shuang

LG

36.5 (23–50)

NR

NR

NR

OG

38.5 (27–50)

NR

NR

NR

Zhao

LG

37 (6–72)

147

5-y: 47

1-y: 87.2, 3-y: 57.2, 5-y: 50.3

OG

141

5-y: 46.8

1-y: 87.1, 3-y: 54.1, 5-y: 49.2

Chen

LG

19 (1–48)

NR

NR

1-y: 91.5

OG

NR

NR

1-y: 89.8

Chun

LG

53.2 (1–82.2)

4

NR

5-y: 91.3

OG

60.4 (7–91.7)

7

NR

5-y: 88.6

Kim

LG

53.7 (8.3−138.1)

13

5-y: 84.6

5-y: 85.9

OG

58.1 (0.3−106.2)

15

5-y: 81.1

5-y: 83.1

Moisan

LG

28

5

3-y: 79.4

3-y: 82.3

OG

40

4

3-y: 83.4

3-y: 86.9

Siani

LG

32.6

NR

5-y: 54.2

5-y: 55.7

OG

31.9

NR

5-y: 52.1

5-y: 52.9

Shinohara

LG

48.8 (25–58.5)a

53

5-y: 65.8b

5-y: 68.1b

OG

34

5-y: 62.0b

5-y: 63.7b

  1. Abbreviations: DFS Disease-free survival, OS Overall survival, y Year, NR Not reported.
  2. Follow-up time are shown as median (range); ashown as interquartile range; bcalculated by excluding stage IA and missing follow-up patients.